Amedeo Smart

Free Medical Literature Service


 

Amedeo

Parkinson's Disease

  Free Subscription

23.02.2026

1 Exp Brain Res
1 J Neural Transm (Vienna)
5 Mov Disord
1 Neurochem Res
1 Neurol Genet
1 Neurology
1 Neurosci Lett
1 Neuroscience
2 PLoS One



    Exp Brain Res

  1. DAVIDSON S, Learman K, Rosenfeldt AB, Zimmerman E, et al
    Parkinson's disease impairs grip force release during a sinusoidal force tracking task.
    Exp Brain Res. 2026;244:46.
    >> Share


    J Neural Transm (Vienna)

  2. WANG H, Li W, Ding Y, Sun Q, et al
    Hyposmia as a predictor of cognitive decline in long-term Parkinson's disease with dementia: a multicenter study in China.
    J Neural Transm (Vienna). 2026 Feb 19. doi: 10.1007/s00702-026-03107.
    >> Share


    Mov Disord

  3. XU T, Yu Y, Deng Z, Li L, et al
    Cortical Morphometric Similarity Network Gradient in Parkinson's Disease and its Association with Gene Expression Profiles.
    Mov Disord. 2026 Feb 20. doi: 10.1002/mds.70233.
    >> Share

  4. PISANI S, Vasa F, Velayudhan L, Bhattacharyya S, et al
    Gray Matter Volume Loss in Parkinson's Disease Psychosis and Cannabinoid Receptor Gene Expression in the Brain.
    Mov Disord. 2026 Feb 20. doi: 10.1002/mds.70222.
    >> Share

  5. OKUBADEJO NU, Schaeffer E, Noyce AJ, Heinzel S, et al
    Addressing Gaps in Parkinson's Disease Etiology: The Need for a Polyexposure Score.
    Mov Disord. 2026 Feb 17. doi: 10.1002/mds.70231.
    >> Share

  6. JAAKKOLA E, Koponen M, Kaasinen V, Hietala J, et al
    Reply to: "Comments on: "Bipolar Disorder as a Long-Term Risk Factor for Parkinson's Disease: A Nationwide Case-Control Study"".
    Mov Disord. 2026 Feb 16. doi: 10.1002/mds.70215.
    >> Share

  7. XIANG N, Cai L, Gao H, Li W, et al
    Comments on: "Bipolar Disorder as a LongTerm Risk Factor for Parkinson's Disease: A Nationwide Case-Control Study".
    Mov Disord. 2026 Feb 16. doi: 10.1002/mds.70214.
    >> Share


    Neurochem Res

  8. ANAYYAT U, Kiani MN, Mei X, Zhang F, et al
    Rotating Magnetic Field Therapy Induces System-Level Neuroprotection in A53T alpha-Synuclein Transgenic Mice Through Coordinated Suppression of Cellular Stress Pathways.
    Neurochem Res. 2026;51:77.
    >> Share


    Neurol Genet

  9. DERING R, Onvumere M, Liu L, Huot P, et al
    Investigating the Genetic Relationship Between Vitamin B12 Metabolism and Parkinson Disease.
    Neurol Genet. 2026;12:e200350.
    >> Share


    Neurology

  10. BENARROCH E
    How Are Synaptic Vesicle Exocytosis and Endocytosis Affected in Parkinson Disease?
    Neurology. 2026;106:e214770.
    >> Share


    Neurosci Lett

  11. LIU KT, Shui Y, Hong J, Xiao L, et al
    Hydrogen sulfide protects dopaminergic neurons via NLRP3 inflammasome inhibition in an MPTP mouse model of Parkinson's disease.
    Neurosci Lett. 2026 Feb 16:138547. doi: 10.1016/j.neulet.2026.138547.
    >> Share


    Neuroscience

  12. SHI X, Liang K, Ma J, Fu C, et al
    The retinal nerve fiber layer mean thickness in patients with early Parkinson's disease reflects striatal dopamine function.
    Neuroscience. 2026;599:94-102.
    >> Share


    PLoS One

  13. ASGHAR A, Chohan TA, Qayyum A, Rana SM, et al
    Unveiling the biochemical potential of Acacia jacquemontii as a therapeutic agent in parkinson's disease: A multi-model in Vitro, In Vivo, and In Silico Study.
    PLoS One. 2026;21:e0334312.
    >> Share

  14. DUPPEN CP, Surkin J, Mahendar S, Saunders J, et al
    The influence of visual input and attention on gait initiation in people with Parkinson disease.
    PLoS One. 2026;21:e0342661.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016